维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：作者名="Findlay M C"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	The variable-rate mortgage and risk in the mortgage market: An option theory perspective: A note显示文摘	Findlay M C Capozza D R	1977	Journal of Money1977，9，2：	1
2	Use of tamoxifen in hepatocellular carcinoma: a review and paradigm shift显示文摘	TAN C K CHOW P K FINDLAY M	2000	J Gastroenterol Hepatol2000，15，7：	1
3	Capecitabine(Xeloda ) improves medical resource use compared with 5--fluorouracil plus leucovorin in a phase Ⅲ trail conducted in patients with advanced colorectal carcinoma显示文摘	Twelves C Boyer M Findlay M	2001	EurJ Cancer2001，37，15：	1
4	Capecitabine(Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase Ⅲ trial conducted in patients with advanced colorectal carcinoma 显示文摘	Twelves C Boyer M Findlay M	2001	Eur J Cancer2001，37，：	1
5	Normal growth of Arabidopsis requires cytosolic invertase but not sucrose synthase显示文摘	Barratt D H P Derbyshire P Findlay K Pike M Wellner N Lunn J Feil R Simpson C Maule AJ and Smith M	2009	PNAS2009，106，13：	1
6	Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase II1 trial conducted in patients with advanced colorectal carcinoma显示文摘	Twelves C Boyer M Findlay M	2001	Eur J Cancer2001，37，5：	1
7	Capecitabine (Xeloda?) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma显示文摘	C Twelves M Boyer M Findlay J Cassidy C Weitzel C Barker B Osterwalder C Jamieson K Hieke	2001	European Journal of Cancer2001，，5：	1
8	The Hong Kong Jury:A Micro-cosm of Society?显示文摘	Duffp Findlay M Howarth C	1990	The International and Comparative Law Quarterly1990，39，4：	1
9	Capecitabine (Xeloda) improves medical resources use compared with 5 - fluorouracil plus leucovorin in a phrase Ⅲ trail conducted in patients with advanced colorectal cancer 显示文摘	TWELVES C BOYER M FINDLAY M	2001	Eur J Cancer2001，37，：	1
10	RANK Expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow,and giant cell tumors of bone显示文摘	Atkins G J Kostakis P Vincent C Farrugia A N Houchins J P Findlay D M	2006	J Bone Miner Res2006，21，：	1
11	U-Pb ages from the Nimish Formation and Montagnais glomeroporphyritic gabbro of the central New Québec Orogen Canada显示文摘	Findlay J M Parrish R R Birkett T C	1995	Canadian Journal of Earth Sciences1995，32，：	1
12	Cluster characteristics ofGeldart group B particles in a pilot-scale CFB riser ( I ):Monodisperse systems 显示文摘	Chew J W Hays R Findlay J G Knowlton T M Karri S BR Cocco R A Hrenya C M	2012	Chemical Engineering Science2012，68，1：	1
13	Response of abenthic microbial community to biotic disturbance 显示文摘	FINDLAY R H TREXLER M B WHITE D C	1990	MarineEcology Progress Series1990，62，12：	1
14	PRODRG,a pro-gram for generating molecular topologies and unique molecular de-scriptors from coordinates of small molecules显示文摘	Aalten D M F Bywater R Findlay J B C	1996	Comput-AidedMol Des1996，10，：	1
15	Dysregulation of cytokine response in Canadian First Nations communities: is there an association with persistent organic pollutant levels? 显示文摘	IMBEAULT P FINDLAY C S ROBIDOUX M A	2012	PloS One2012，7，39：	1
16	The variable-rate mortgage and risk in the mortgage market: an option theory perspective: a note 显示文摘	FINDLAY M C CAPOZZA D R	1977	Journal of Money Credit and Banking1977，9，2：	1
17	Capecitabine improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase Ⅲ trial conducted in patients with advanced colorectal carcinoma显示文摘	Twelves C Boyer M Findlay M	2001	Eur J Cancer2001，37，：	1
18	The aspect ratio (dome/neck) of rup- tured and unruptured aneurysms 显示文摘	Weir B Amidei C Kongable G Findlay J M Kassell N F Kelly J	2003	J Neurosurg2003，99，：	1
19	Apecitabine(Xeloda^TM)improves medical resource use compared with 5-fluorouracil plus leueovorin in a phase Ⅲ trial conducted in patients with advanced coloectal carcinoma 显示文摘	Twelves C Boyer M Findlay M	2001	European Journal of Cancer2001，37，5：	1
20	Monoclonal antibody TGN1412 trial failure explained by spe- cies differences in CD28 expression on CD4 + effector memory T- cells 显示文摘	Eastwood D Findlay L Poole S Bird C Wadhwa M Moore M	2010	Br J Pharmacol2010，161，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示